Search - tctmd.com

Displaying 201 - 220 of 511

Sort: Relevancy | Date

Presentation ACC 2018

High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS

Presenter: Sonia S. Anand

March 11, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

News Daily News

Varicose Veins Linked to Increased Risk of DVT

L.A. McKeown

February 28, 2018

News Conference News ISET 2018

WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy

Caitlin E. Cox

February 13, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Caitlin E. Cox

February 08, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Conference News ISET 2018

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

Caitlin E. Cox

February 05, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

L.A. McKeown

December 04, 2017

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Daily News

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

L.A. McKeown

October 09, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

Podcast TCTMD Talking Points

Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries

September 06, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

L.A. McKeown

July 25, 2017

Advertisement

High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS

TCTMD’s Top 10 Most Popular Stories for February 2018

Varicose Veins Linked to Increased Risk of DVT

WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Next-Generation Large-Bore Closure Devices Arrive

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Burden of Readmission High in PAD Patients Following Revascularization

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Two-year Results from the IN.PACT Global Study

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content